3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer | MicrobiomeTrials← Back to trialsNCT00935090
3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
RecruitingINTERVENTIONAL
Trial Details
Start: 2009-09Est. Completion: 2024-04-04
Locations- Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States
Other microbiome trials you might be interested in
Lysosomal DiseasesGangliosidosisGM1
Background:
GM1 gangliosidosis is a disorder that destroys nerve cells. It is fatal. There is no treatment. People with…
Bethesda, United StatesEst. completion Jan 1, 2030
Metastatic Malignant Neoplasm in the Brain
This phase III trial compares the usual treatment of surgery after stereotactic radiosurgery (SRS) to receiving SRS befo…
Phoenix, United StatesEst. completion Mar 16, 2027
Advanced Lung Non-Squamous Non-Small Cell CarcinomaMetastatic Lung Non-Squamous Non-Small Cell CarcinomaRecurrent Lung Non-Squamous Non-Small Cell CarcinomaStage IIIB Lung Cancer AJCC v8Stage IV Lung Cancer AJCC v8
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatm…
Anchorage, United StatesEst. completion Dec 31, 2026